Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.
Overview
- Phase
- Not Applicable
- Intervention
- liposomal bupivacaine
- Conditions
- Hip Injuries
- Sponsor
- Trinity Health Of New England
- Enrollment
- 23
- Locations
- 1
- Primary Endpoint
- Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
Detailed Description
Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients having hip arthroscopy
Exclusion Criteria
- •History of neurologic disease, neuropathy, diabetes
- •Allergy to local anesthetic solution
- •Chronic use of narcotics
- •Inability to give consent/cooperate with study
- •History of previous hip arthroscopy on the ipsilateral side
- •Pregnancy
Arms & Interventions
Liposomal bupivacaine
Ultrasound guided injection of liposomal bupivacaine for patients undergoing hip arthroscopy
Intervention: liposomal bupivacaine
Bupivacaine
Bupivacaine (around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy
Intervention: Bupivacaine
Outcomes
Primary Outcomes
Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)
Time Frame: Post Operative Day 1, 2 & 3
Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.
Secondary Outcomes
- Pain Scores(Post Operative Day 1, 2 & 3)